Primary Record
pentostatin
- In stock
- 5,847 g
- Purity
- 98.6 %
- CAS
- 53910-25-1
Compound Identifiers & Properties
- CAS
- 53910-25-1
- PubChem CID
- 439693
- SMILES
- C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2NC=NC[C@H]3O)CO)O
- Canonical SMILES
- OC[C@H]1O[C@@H](n2cnc3c2NC=NC[C@H]3O)C[C@@H]1O
Names & Synonyms
- pentostatin
- Deoxycoformycin
- Nipent
- 2'-Deoxycoformycin
- CO-Vidarabine
- Pentostatina
- Pentostatine
- Vidarbine
- Covidarabine
- Pentostatinum
- Coforin
- Oncopent
- 53910-25-1
- 2'-Dexoycoformycin
- PD-ADI
- Co-V
- Nipent (TN)
- (R)-Deoxycoformycin
- 2'-DCF
- 2' Deoxycoformycin
- Vira A deaminase inhibitor
- Pentostatin (PTN)
- (R)-2'-Deoxycoformycin
- 8R-2'-Deoxycoformycin
- CI-825
- YK-176
- 2 -Deoxycoformycin
- Deaminase inhibitor (PD)
- Pentostatin (Standard)
- RefChem:57393
- NSC-218321
- Pentostatine [INN-French]
- Pentostatinum [INN-Latin]
- CI-825;Deoxycoformycin
- PENTOSTATIN [MI]
- Pentostatina [INN-Spanish]
- PENTOSTATIN [INN]
- PENTOSTATIN [JAN]
- DTXSID2023436
- PENTOSTATIN [HSDB]
- PENTOSTATIN [USAN]
- D0T3AD
- 2 -Deoxy-D-coformycin
- PENTOSTATIN [VANDF]
- AC1L97UQ
- Pentostatin (JAN/USAN/INN)
- SCHEMBL2817
- DTXCID403436
- PD 81565
- PD-81565
- CHEMBL1580
- PENTOSTATIN [MART.]
- PENTOSTATIN [WHO-DD]
- UNII-395575MZO7
- HSDB 6547
- BIDD:GT0136
- FPVKHBSQESCIEP-JQCXWYLXSA-N
- MFCD00078802
- NSC218321
- C11H16N4O4
- GTPL4805
- SCHEMBL1649740
- 395575MZO7
- NSC 218321
- Pentostatin [USAN:INN:BAN:JAN]
- BDBM22925
- CHEBI:27834
- HY-A0006R
- Pentostatin, >=95% (HPLC)
- L01XX08
- PENTOSTATIN [ORANGE BOOK]
- CI 825
- BDBM223291
- CI825
- GLXC-05480
- AMY10324
- HY-A0006
- Pentostatin [USAN:BAN:INN:JAN]
- ZINC3806262
- BRN 1223097
- Tox21_113417
- CID439693
- EBC-08665
- MSK164430
- NCGC00182045-01
- s9521
- AKOS024456918
- AKOS032949742
- C11-H16-N4-O4
- CL 67310465
- CL-67310465
- AD03945
- CS-0374
- DB00552
- RL03997
- NCGC00388420-02
- Deaminase, inhibitor for adenosine arabinoside
- J10.843J
- AB0010579
- CAS-53910-25-1
- A3708
- NS00005086
- C02267
- D00155
- EN300-222177
- Q-4464
- dCF
- 910P251
- A829822
- Q425470
- SR-01000883935
- (8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
- SR-01000883935-1
- BRD-K91543828-001-02-0
- (8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
- (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol
- (R)-3-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
- Adenosine Deaminase Inhibitor, DCF - CAS 53910-25-1
- Z2204459563
- (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol
- (R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol
- (R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol
- (8R)-3-(2-Deoxy-?-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
- (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol
- Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-
- Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-
- (8R)-3,4,7,8-Tetrahydro-3-(2-deoxy-beta-D-erythro-pentofuranosyl)imidazo[4,5-d][1,3]diazepine-8-ol
- (8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H,4H,7H,8H-imidazo(4,5-d)(1,3)diazepin-8-ol
- (8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H,6H,7H,8H-imidazo(4,5-d)(1,3)diazepin-8-ol
- (8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-7,8-dihydro-4H-imidazo(4,5-d)(1,3)diazepin-8-ol
- (8R)-3-(2-Deoxy-b-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
- (8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]-diazepin-8-ol
- (8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8beta-ol
- (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol
- (8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-8-ol
- (R)-3-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
- (R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol
- 63677-95-2
- 637-271-5
- Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-
- Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-
- Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-
- Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-
- Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-b-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-
- N/A